Update: Pfizer Opposes Lipitor MDL

Last month we told you that a group of Plaintiffs had filed a motion to consolidate all federal Lipitor diabetes lawsuits before one South Carolina judge as part of a Multi-District Litigation or MDL.  To date, at least five different Lipitor lawsuits have been filed against Pfizer in three different U.S. District Courts throughout the country. The motion indicates that numerous additional complaints are expected.

lipitorNot surprising, Pfizer has indicated that they are opposed to the formation of coordinated proceedings involving Lipitor, arguing that the litigation is not sufficient big enough to require the consolidated proceedings and that such a procedure would only result in a wave of lawsuits filed by lawyers who may not otherwise be willing to litigate claims.

Lipitor has been linked to diabetes. Lipitor prevents an enzyme in the liver from creating low density lipids (LDLs).  The drug works to prevent the production of LDLs, a type of cholesterol that blocks arteries, and reduce the user’s risk of developing heart disease. Lipitor, which generates more than $14.5 billion in combined annual sales, is among the best selling drugs in the world.

This would not be the first Lipitor MDL. U.S. District Judge Peter Sheridan presides over an MDL in New Jersey. In that case,  plaintiffs’ lawyers allege Pfizer improperly extended its patent rights on the anticholesterol drug Lipitor and then when the rights were expiring,  conspired with the a generic drug manufacturer Ranbaxy to block the generic version of the drug.  This lawsuit is a totally different animal but there is a common thread to both cases: allegations that Pfizer is greedy.

The U.S. JPML is expected to schedule oral arguments over the motion to consolidate the Lipitor diabetes litigation for an upcoming hearing session, scheduled for July 25, 2013.

We will continue to give you the latest updates in the Lipitor cases.  Bookmark this page.

And… if you think you have a potential Lipitor claim – particularly if you are a woman with diabetes – we will give you a free on-line case evaluation.


One thought on “Update: Pfizer Opposes Lipitor MDL

  1. “Egbe nnem pa-a nyeu-m, pa a- nyeu-m, enwerem okuko?” Translated:HAWK! my friend please share your loot with me(It is noteworthy that the hawk snags chicks) afterall, do I own a chick?” I do NOT own a chick that will be snagged by a HAWK! Back home in Nigeria where we reared chickens all of the ones named mine will always come home! They all knew their ways back. BUT, this is a different story from any chick named as one of my brothers. They NEVER come back home! OR they lay lay just one egg! hahahahaha! THEN! one of my brothers, I only have two (The problem will lie when I am asked to identify which is which WILL NOT!) His chickens will multiply with reciprocity! However, if any of his chicks misbehaves by climbing on a tree instead of just coming home to roost, stays there all defiant or confused, crowing in disturbance of the compound, he will climb the tree get that renegade chick and give it a whipping, and will keep saying to it, you live here! Believe it or not, this dumb chick, never did such stupidity anymore! Hahahahahaha! Ahhh The simple good life we shared when we visited the village from the city! Life was good in rural Nigeria! Thank God for the memories! As for Pfizer, the pharmaceutical company in question here, if they got so greedy and sold in billions of dollars and they did, and failed to adequately warn the public of the potential dangers of this medication so that their patients are the “rijuo afo dashie uzo’s” AND the “ije mgbati sukoro’s” Translated:”To feast at a gourmet restaurant, and die along the way right after from the food.” AND to go for betterment, and come out permanently maimed.”THEN! they should be made to cough up some so it spills to the people they maimed!

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>